查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1537058

抗栓塞防护袜市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2032年

Anti-Embolism Stockings Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球栓塞防护袜市场的综合报告。该报告全面评估了主要市场动态，包括驱动因素、趋势、机会和挑战，并提供了对市场结构的详细见解。

主要的洞察：栓塞防护袜市场

  • 市场规模（2024 年）：7.94 亿美元
  • 市场预测金额（2032 年）：11.996 亿美元
  • 全球市场成长率（2024-2032 年复合年增长率）：5.3%

栓塞防护袜市场 - 研究范围：

抗栓袜在预防深部静脉栓塞（DVT）和其他静脉血栓栓塞（VTE）方面发挥重要作用。这些长袜逐渐压缩腿部，增加血液循环并降低血栓形成的风险。栓塞防护袜市场面向医院、诊所、门诊手术中心和家庭护理机构，提供各种袜型和压力级别，以满足不同患者的需求。市场成长的推动因素包括 VTE 预防意识的提高、慢性静脉疾病盛行率的增加以及库存材料和设计的进步。

推动市场成长的因素：

全球栓塞防护袜市场由几个关键因素推动，包括医疗保健提供者和患者对 VTE 预防意识的提高。手术数量的增加以及肥胖、癌症和心血管疾病盛行率的增加，增加了 DVT 的风险，进一步推动了市场的扩张。技术进步，例如开发具有改进的透气性、舒适性和抗菌特性的长袜，正在提高患者的依从性和治疗结果，推动市场成长。此外，家庭医疗保健和预防保健的日益普及为市场参与者接触更广泛的患者群体开闢了新的途径。

市场限制因素：

儘管预计栓塞防护袜市场将呈现良好的成长势头，但它仍面临患者依从性、报销政策以及来自替代 VTE 预防方法的竞争等方面的挑战。患者持续??穿着压力袜会因不适和不便而导致依从率低，进而影响治疗效果。特别是在医疗保健预算有限的新兴国家，报销范围有限以及栓塞防护袜价格高昂，对市场渗透构成了挑战。应对这些挑战需要开展教育工作以提高患者的依从性，并开展宣传工作以改善报销政策，以促进获得有效的 VTE 预防解决方案。

市场机会：

在人口趋势、技术创新和不断发展的医疗保健服务模式的推动下，栓塞防护袜市场呈现出巨大的成长机会。世界人口老化和慢性病的增加增加了对预防性保健产品（包括栓塞防护袜）的需求。智慧纺织品和数位健康技术（例如用于即时监测压力水平和患者依从性的可穿戴感测器）的集成，可以改善产品功能和患者治疗结果。策略伙伴关係、研发投资以及采用具有成本效益且易于使用的栓塞防护袜对于利用新机会并在动态的栓塞防护领域保持市场领先地位至关重要。

本报告解决的关键问题

  • 推动全球抗栓袜市场成长的关键因素是什么？
  • 哪些袜子类型和应用正在推动不同医疗机构采用栓塞防护袜？
  • 技术进步如何改变栓塞防护袜市场的竞争格局？
  • 谁是栓塞防护袜市场的主要参与者？
  • 全球抗栓袜市场的新趋势与未来前景如何？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制
  • 蕴藏事项·除外事项

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势

第4章 主要成功因素

  • 主要的推销策略:各製造厂商
  • 法规情形
  • 价值链分析
  • 产品采用分析
  • PESTEL分析
  • 波特分析

第5章 市场背景

  • 宏观经济要素
  • 预测要素 - 相关性及影响
  • 市场动态

第6章 COVID-19危机分析

  • COVID-19及影响分析
    • 各产品
    • 人口统计别
    • 各终端用户
    • 各地区
  • 2024年的市场情境

第7章 全球市场的数量(单位)分析

  • 过去的市场数量(单位)分析，2019年～2023年
  • 现在及未来市场数量(单位)预测，2024年～2032年
    • 与前一年同期比较成长趋势分析

第8章 全球市场 - 价格分析

  • 各地区价格分析:各产品
  • 价格的明细
    • 厂商层级的价格设定
    • 分销商层级的价格设定
  • 世界平均价格分析基准

第9章 全球市场的需求(金额或规模，一百万美元)分析

  • 过去的市场金额(一百万美元)分析，2019年～2023年
  • 现在及未来市场金额(一百万美元)预测，2024年～2032年
    • 与前一年同期比较成长趋势分析
    • 绝对额的机会分析

第10章 全球市场分析:各产品

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析:各产品，2019年～2023年
  • 现在及未来市场规模(一百万美元)分析与预测:各产品，2024年～2032年
    • 小腿长度
    • 大腿长度
  • 市场魅力分析:各产品

第11章 全球市场分析:人口统计别

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)分析:人口统计别，2019年～2023年
  • 现在及未来市场规模(一百万美元)分析与预测:人口统计别，2024年～2032年
    • 男性
    • 女性
  • 市场魅力分析:人口统计别

第12章 全球市场分析:各终端用户

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)分析:各终端用户，2019年～2023年
  • 现在及未来市场规模(一百万美元)分析预测:各终端用户，2024年～2032年
    • 门诊病人
    • 术后患者
    • 孕妇
    • 其他
  • 市场魅力分析:各终端用户

第13章 全球市场分析:各地区

  • 简介
  • 过去的市场规模(一百万美元)的分析:各地区，2019年～2023年
  • 现在及未来市场金额(一百万美元)预测，2024年～2032年
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东·非洲(MEA)
  • 各地区市场的魅力分析

第14章 北美市场分析

第15章 南美市场分析

第16章 欧洲市场分析

第17章 东亚市场分析

第18章 南亚市场分析

第19章 大洋洲市场

第20章 中东·非洲(MEA)市场分析

第21章 市场结构分析

  • 市场分析:企业各层级
  • 主要企业的市场占有率分析
  • 市场影响分析

第22章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争的详细资讯
    • MD
    • Medtronic(Covidien)
    • Sigvaris, Medi
    • BSN Medical
    • Juzo
    • 3M
    • Bauerfeind AG
    • Thuasne Corporate
    • Pretty Legs Hosiery
    • Salzmann-Group
    • Paul Hartmann
    • Cizeta Medicali
    • Belsana Medical
    • Gloria Med
    • Zhende Medical Group
    • Maizi
    • TOKO
    • Okamoto Corporation
    • Zhejiang Sameri

第23章 所使用的前提条件与缩写

第24章 调查手法

简介目录
Product Code: PMRREP33355

Persistence Market Research has recently released a comprehensive report on the worldwide market for anti-embolism stockings. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Anti-Embolism Stockings Market

  • Market Size (2024E): USD 794 Million
  • Projected Market Value (2032F): USD 1199.6 Million
  • Global Market Growth Rate (CAGR 2024 to 2032):5.3%

Anti-Embolism Stockings Market - Report Scope:

Anti-embolism stockings play a crucial role in the prevention of deep vein thrombosis (DVT) and other venous thromboembolic events (VTEs). These stockings apply graduated compression to the legs, enhancing blood circulation and reducing the risk of clot formation. The anti-embolism stockings market caters to hospitals, clinics, outpatient surgical centers, and homecare settings, offering a range of stocking types and compression levels to meet diverse patient needs. Market growth is driven by increasing awareness of VTE prevention, rising incidences of chronic venous disorders, and advancements in stocking materials and designs.

Market Growth Drivers:

The global anti-embolism stockings market is propelled by several key factors, including the growing awareness about VTE prevention among healthcare providers and patients. The rising number of surgical procedures and the increasing prevalence of conditions such as obesity, cancer, and cardiovascular diseases, which heighten the risk of DVT, further drive market expansion. Technological advancements, such as the development of stockings with improved breathability, comfort, and antimicrobial properties, enhance patient compliance and treatment outcomes, fostering market growth. Moreover, the growing adoption of home-based care and preventive healthcare practices creates new avenues for market players to reach a broader patient population.

Market Restraints:

Despite promising growth prospects, the anti-embolism stockings market faces challenges related to patient compliance, reimbursement policies, and competition from alternative VTE prevention methods. Patient adherence to wearing compression stockings consistently can be low due to discomfort or inconvenience, impacting treatment efficacy. Limited reimbursement coverage for anti-embolism stockings and the high cost of premium products pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these challenges requires education initiatives to improve patient compliance and advocacy for better reimbursement policies to promote access to effective VTE prevention solutions.

Market Opportunities:

The anti-embolism stockings market presents significant growth opportunities driven by demographic trends, technological innovations, and evolving healthcare delivery models. The aging global population and the rising incidence of chronic diseases create a growing demand for preventive healthcare products, including anti-embolism stockings. The integration of smart textiles and digital health technologies, such as wearable sensors for real-time monitoring of compression levels and patient compliance, enhances product functionality and patient outcomes. Strategic partnerships, investment in research and development, and the introduction of cost-effective, user-friendly anti-embolism stockings are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic anti-embolism landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the anti-embolism stockings market globally?
  • Which stocking types and applications are driving anti-embolism stockings adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the anti-embolism stockings market?
  • Who are the key players contributing to the anti-embolism stockings market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global anti-embolism stockings market?

Competitive Intelligence and Business Strategy:

Leading players in the global anti-embolism stockings market, including Sigvaris, Medi GmbH & Co. KG, and BSN Medical Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced anti-embolism stockings with enhanced comfort, durability, and therapeutic efficacy, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving anti-embolism landscape.

Key Companies Profiled:

  • Medtronic (Covidien)
  • Sigvaris
  • Medi
  • BSN Medical
  • Juzo
  • 3M
  • Bauerfeind AG
  • Thuasne Corporate
  • Pretty Legs Hosiery
  • Salzmann-Group
  • Paul Hartmann
  • Cizeta Medicali
  • Belsana Medical
  • Gloria Med

Anti-Embolism Stockings Industry Research Segmentation

By Product:

  • Calf-length
  • Thigh-length

By Demography:

  • Men
  • Women

By End User:

  • Ambulatory Patients
  • Post-operative Patients
  • Pregnant Women

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies by Manufacturers
  • 4.2. Regulatory Landscape
  • 4.3. Value Chain Analysis
  • 4.4. Product Adoption Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Historical Growth of Top Companies
    • 5.2.2. Adoption Rate
    • 5.2.3. Technology Advancements
    • 5.2.4. Increasing Deep Vein Thrombosis Cases
    • 5.2.5. Product Pricing
    • 5.2.6. Favorable Reimbursement Policies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Demography
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 10.3.1. Calf Length
    • 10.3.2. Thigh Length
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Demography

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Demography, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Demography, 2024-2032
    • 11.3.1. Men
    • 11.3.2. Women
  • 11.4. Market Attractiveness Analysis By Demography

12. Global Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By End User, 2024-2032
    • 12.3.1. Ambulatory Patients
    • 12.3.2. Post-Operative Patients
    • 12.3.3. Pregnant Women
    • 12.3.4. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Demography
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Demography
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Demography
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Demography
        • 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Demography
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Demography
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Demography
        • 15.7.1.2.3. By End User
    • 15.7.2. Mexico Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Demography
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Demography
        • 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. U.K.
      • 16.3.1.2. Germany
      • 16.3.1.3. Italy
      • 16.3.1.4. France
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Demography
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Demography
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. U.K. Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Demography
        • 16.7.1.2.3. By End User
    • 16.7.2. Germany Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Demography
        • 16.7.2.2.3. By End User
    • 16.7.3. Italy Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Demography
        • 16.7.3.2.3. By End User
    • 16.7.4. France Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Demography
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Market Analysis
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Product
        • 16.7.5.2.2. By Demography
        • 16.7.5.2.3. By End User
    • 16.7.6. Russia Market Analysis
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Product
        • 16.7.6.2.2. By Demography
        • 16.7.6.2.3. By End User
    • 16.7.7. BENELUX Market Analysis
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Product
        • 16.7.7.2.2. By Demography
        • 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Demography
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Demography
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. China Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Demography
        • 17.7.1.2.3. By End User
    • 17.7.2. Japan Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Demography
        • 17.7.2.2.3. By End User
    • 17.7.3. South Korea Market Analysis
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Product
        • 17.7.3.2.2. By Demography
        • 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Demography
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Demography
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. India Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Demography
        • 18.7.1.2.3. By End User
    • 18.7.2. Indonesia Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Demography
        • 18.7.2.2.3. By End User
    • 18.7.3. Malaysia Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Demography
        • 18.7.3.2.3. By End User
    • 18.7.4. Thailand Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Demography
        • 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Demography
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Demography
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Market Analysis
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Product
        • 19.7.1.2.2. By Demography
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Market Analysis
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Product
        • 19.7.2.2.2. By Demography
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Demography
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Demography
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Market Analysis
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Product
        • 20.7.1.2.2. By Demography
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkiye Market Analysis
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Product
        • 20.7.2.2.2. By Demography
        • 20.7.2.2.3. By End User
    • 20.7.3. South Africa Market Analysis
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Product
        • 20.7.3.2.2. By Demography
        • 20.7.3.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. MD
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. Key Financials
      • 22.3.1.6. SWOT Analysis
      • 22.3.1.7. Strategy Overview
    • 22.3.2. Medtronic(Covidien)
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. Key Financials
      • 22.3.2.6. SWOT Analysis
      • 22.3.2.7. Strategy Overview
    • 22.3.3. Sigvaris, Medi
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. Key Financials
      • 22.3.3.6. SWOT Analysis
      • 22.3.3.7. Strategy Overview
    • 22.3.4. BSN Medical
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. Key Financials
      • 22.3.4.6. SWOT Analysis
      • 22.3.4.7. Strategy Overview
    • 22.3.5. Juzo
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. Key Financials
      • 22.3.5.6. SWOT Analysis
      • 22.3.5.7. Strategy Overview
    • 22.3.6. 3M
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. Key Financials
      • 22.3.6.6. SWOT Analysis
      • 22.3.6.7. Strategy Overview
    • 22.3.7. Bauerfeind AG
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. Key Financials
      • 22.3.7.6. SWOT Analysis
      • 22.3.7.7. Strategy Overview
    • 22.3.8. Thuasne Corporate
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. Key Financials
      • 22.3.8.6. SWOT Analysis
      • 22.3.8.7. Strategy Overview
    • 22.3.9. Pretty Legs Hosiery
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. Key Financials
      • 22.3.9.6. SWOT Analysis
      • 22.3.9.7. Strategy Overview
    • 22.3.10. Salzmann-Group
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. Key Financials
      • 22.3.10.6. SWOT Analysis
      • 22.3.10.7. Strategy Overview
    • 22.3.11. Paul Hartmann
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. Key Financials
      • 22.3.11.6. SWOT Analysis
      • 22.3.11.7. Strategy Overview
    • 22.3.12. Cizeta Medicali
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. Key Financials
      • 22.3.12.6. SWOT Analysis
      • 22.3.12.7. Strategy Overview
    • 22.3.13. Belsana Medical
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.13.4. Sales Footprint
      • 22.3.13.5. Key Financials
      • 22.3.13.6. SWOT Analysis
      • 22.3.13.7. Strategy Overview
    • 22.3.14. Gloria Med
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.14.4. Sales Footprint
      • 22.3.14.5. Key Financials
      • 22.3.14.6. SWOT Analysis
      • 22.3.14.7. Strategy Overview
    • 22.3.15. Zhende Medical Group
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.15.4. Sales Footprint
      • 22.3.15.5. Key Financials
      • 22.3.15.6. SWOT Analysis
      • 22.3.15.7. Strategy Overview
    • 22.3.16. Maizi
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.16.4. Sales Footprint
      • 22.3.16.5. Key Financials
      • 22.3.16.6. SWOT Analysis
      • 22.3.16.7. Strategy Overview
    • 22.3.17. TOKO
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.17.4. Sales Footprint
      • 22.3.17.5. Key Financials
      • 22.3.17.6. SWOT Analysis
      • 22.3.17.7. Strategy Overview
    • 22.3.18. Okamoto Corporation
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.18.4. Sales Footprint
      • 22.3.18.5. Key Financials
      • 22.3.18.6. SWOT Analysis
      • 22.3.18.7. Strategy Overview
    • 22.3.19. Zhejiang Sameri
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.19.4. Sales Footprint
      • 22.3.19.5. Key Financials
      • 22.3.19.6. SWOT Analysis
      • 22.3.19.7. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology